The FDA posted on Jan. 19 a set of recommendations to mitigate the shortage:
- Only perform blood draws considered medically necessary, remove duplicate test orders, avoid testing too often and extend time intervals between tests when possible.
- Reduce tests at routine wellness visits and allergy testing only to those that target specific disease states or where it will change patient treatment.
- Consider add-on testing or sharing samples between laboratory departments if previously collected specimens are available.
- If a discard tube is needed, use a tube type that the facility has more of.
- Consider point-of-care testing that does not require using blood specimen collection tubes, such as lateral flow tests.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.